Literature DB >> 11354541

Biomarker monitoring for health risk based on sensitivity to environmental mutagens.

W W Au1, B Oberheitmann, M Y Heo, W Hoffmann, H Y Oh.   

Abstract

Ongoing human and environmental genome programs have generated a tremendous amount of information regarding the genetic basis for human disease. The information can be used to enhance existing bioassays, as well as to develop new bioassays for improving human monitoring with the goal of disease prevention. In this review, some biomarkers that can be used for the purpose are presented, with an emphasis on using biomarkers to monitor human sensitivity to environmental mutagens. The application of biomarkers in clarifying the role of inherited and acquired susceptibility for developing environmental disease will be discussed. We emphasize the use of biomarkers that can detect mutagen sensitivity and DNA repair deficiency in the humans as an indication of susceptibility to disease. Such sensitivity can be either genetically determined or acquired from the exposure to environmental mutagens.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354541     DOI: 10.1515/reveh.2001.16.1.41

Source DB:  PubMed          Journal:  Rev Environ Health        ISSN: 0048-7554            Impact factor:   3.458


  2 in total

1.  Comparison of the use of mussels and semipermeable membrane devices for monitoring and assessment of accumulation of mutagenic pollutants in marine environment in combination with a novel microbiological mutagenicity assay.

Authors:  Ewa Cheć; Beata Podgórska; Grzegorz Wegrzyn
Journal:  Environ Monit Assess       Date:  2007-06-12       Impact factor: 2.513

2.  The use of the Vibrio harveyi luminescence mutagenicity assay as a rapid test for preliminary assessment of mutagenic pollution of marine sediments.

Authors:  Beata Podgórska; Ksenia Pazdro; Grzegorz Wegrzyn
Journal:  J Appl Genet       Date:  2007       Impact factor: 2.653

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.